Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies

Cell Res. 2020 Mar;30(3):276-278. doi: 10.1038/s41422-019-0267-z. Epub 2020 Jan 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • Gene Editing*
  • Genetic Therapy
  • Hematopoietic Stem Cells
  • Hemoglobinopathies* / genetics
  • Hemoglobinopathies* / therapy
  • Humans
  • Promoter Regions, Genetic
  • gamma-Globins* / genetics
  • gamma-Globins* / metabolism

Substances

  • gamma-Globins